US Broker Ratings

BGM Group Ltd. (BGM) Stock Analysis: Revenue Plunge and Strategic Shifts in Focus for Investors

BGM Group Ltd. (BGM), a player in the healthcare sector with a focus on the specialty and generic drug manufacturing industry, is navigating challenging market conditions...

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Exploring Robust Revenue Growth and a Solid Market Position

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a prominent player in the healthcare sector, particularly within the medical instruments and supplies industry, has been capturing the attention of..

Recursion Pharmaceuticals (RXRX) Stock Analysis: Navigating a 98% Potential Upside in the Biotech Arena

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is garnering significant attention in the biotechnology sector, particularly due to its impressive 98.06% potential upside as indicated by analyst target..

Vericel Corporation (VCEL) Stock Analysis: A 71.66% Potential Upside in Biotech

Vericel Corporation (NASDAQ: VCEL), a prominent player in the biotechnology sector, is capturing investor attention with a potential upside of 71.66%, according to analyst consensus. Headquartered..

Adaptive Biotechnologies Corpor (ADPT) Stock Analysis: A 56% Upside Potential Amid Strong Revenue Growth

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a pioneering entity in the biotechnology sector, is capturing the attention of investors with its promising 56.59% potential upside. As a..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a 50% Upside in the Healthcare Sector

Kestra Medical Technologies, Ltd. (KMTS) has emerged as a noteworthy player within the healthcare sector, specifically in the medical instruments and supplies industry. Based in Kirkland,..

Clover Health Investments (CLOV): Evaluating the 51% Potential Upside for Investors

Clover Health Investments, Corp (NASDAQ: CLOV), a player in the healthcare plans sector, is grabbing attention with its significant potential upside of 51.44%. This enticing figure..

Disc Medicine, Inc. (IRON) Stock Analysis: Exploring a 64.5% Potential Upside in the Biotech Sector

Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company, is gaining attention from investors due to its promising pipeline aimed at addressing serious hematologic diseases. With..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Unlocking a Potential 52% Upside in Biotech Innovation

Travere Therapeutics, Inc. (NASDAQ: TVTX), a prominent player in the biotechnology sector, is capturing investor attention with its innovative therapeutic solutions targeting rare kidney and metabolic..

Azenta, Inc. (AZTA) Investor Outlook: Positioned for an 84.92% Upside with Promising Analyst Ratings

Azenta, Inc. (NASDAQ: AZTA), a prominent player in the healthcare sector’s medical instruments and supplies industry, offers a unique investment opportunity with a notable potential upside..

Apogee Therapeutics, Inc. (APGE) Investor Outlook: Potential 48.91% Upside with Strong Buy Ratings

Investors looking for opportunities in the biotech sector may want to keep a close eye on Apogee Therapeutics, Inc. (NASDAQ: APGE). Based in Waltham, Massachusetts, this..

Biohaven Ltd. (BHVN) Stock Analysis: Unpacking a Potential 128.86% Upside in Biotech

Biohaven Ltd. (BHVN), a burgeoning player in the biotechnology sector, is gaining substantial attention from investors due to its ambitious pipeline and significant potential upside. With..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Potential Upside of 97% Beckons Investors

Investors with an eye on the biotechnology sector may want to take a closer look at Vera Therapeutics, Inc. (NASDAQ: VERA), a promising player in the..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Exploring a 92% Potential Upside in the Biotech Sector

Structure Therapeutics Inc. (GPCR) presents a compelling opportunity for investors in the biotechnology sector, with recent analyst ratings suggesting a substantial potential upside of 92.29%. The..

Pediatrix Medical Group (MD) Stock Analysis: Evaluating a 9.46% Potential Upside in the Healthcare Sector

Pediatrix Medical Group, Inc. (NYSE: MD) stands out in the healthcare sector with its specialized focus on providing neonatal and maternal-fetal medical care. As a key..

Dynavax Technologies Corporation (DVAX): Investor Outlook on Potential Upside and Revenue Growth

Dynavax Technologies Corporation (NASDAQ: DVAX) is making waves in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. As a commercial-stage biopharmaceutical company,..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring a 72.94% Potential Upside Amidst Groundbreaking Gene Editing Innovations

CRISPR Therapeutics AG (NASDAQ: CRSP) stands at the forefront of the biotechnology revolution with its pioneering work in gene editing. This Swiss-based company, operating within the..

Omnicell, Inc. (OMCL) Stock Analysis: A 67% Upside Potential Amid Healthcare Technology Innovation

Omnicell, Inc. (OMCL), a prominent player in the healthcare technology sector, is capturing investor attention with its robust growth potential. With a market capitalization of $1.56..

AtriCure, Inc. (ATRC) Stock Analysis: Exploring the 62.20% Potential Upside

For investors seeking opportunities in the healthcare sector, AtriCure, Inc. (NASDAQ: ATRC) presents a fascinating prospect with its significant potential upside of 62.20%. Specializing in innovative..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: Why Analysts Are Bullish with a 37% Potential Upside

Scholar Rock Holding Corporation (NASDAQ: SRRK) is gaining significant attention in the biotechnology sector for its promising pipeline of treatments targeting rare neuromuscular diseases. With a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds